XBI

SPDR S&P Biotech ETF
*Unless otherwise stated, data provided by FactSet.

XBI Fund Description

XBI tracks an equal-weighted index of US biotechnology stocks.

XBI Factset Analytics Insight

XBI provides exposure to US biotech stocks, as defined by GICS, from a universe that invests across the market-cap spectrum. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market-cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. The index is rebalanced quarterly.

PERFORMANCE [as of 08/03/22] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
XBI 9.82% 9.38% -24.92% -32.66% 0.10% 1.93% 11.72%
XBI (NAV) 9.94% 9.59% -24.77% -32.51% 0.15% 1.95% 11.73%
S&P Biotechnology Select Industry Index 9.96% 9.56% -24.72% -32.39% 0.23% 1.99% 11.55%
MSCI USA IMI / Biotechnology -IND -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

XBI Summary Data

SPDR
01/31/06
Open-Ended Fund
0.35%
$7.45B
$942.38M
0.02%

XBI Portfolio Data

$11.30B
-6.77
3.17
0.04%
09/19/22
157

XBI Index Data

Equal
Market Cap
MSCI USA IMI / Biotechnology -IND

XBI Portfolio Management

0.35%
-0.13%
0.01%
-0.18%

XBI Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

XBI Fund Structure

Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily

XBI Factset Analytics Block Liquidity

As of 08/04/22
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XBI. XBI is rated a 5 out of 5.

XBI Tradability

12,441,564
$942.38M
11,919,847
$892.75M
0.02%
$0.01
0.01%
0.22% / -1.24%
None
94.00%
25,000
476.79
0.01%
0.07%
897,171
$84.16
5

XBI Sector/Industry Breakdown


XBI
Segment Benchmark
96.70%
--
1.95%
--
1.32%
--
0.02%
--
0.00%
--

XBI Countries


XBI
Segment Benchmark
100.00%
--

XBI Regions


XBI
Segment Benchmark
100.00%
--

XBI Economic Development


XBI
Segment Benchmark
100.00%
--

XBI Performance Statistics

--
--
--
--
--
MSCI USA IMI / Biotechnology -IND

XBI Benchmark Comparison Holdings

157
--
--
--

XBI Benchmark Comparison Summary


XBI
Segment Benchmark
157
--
$11.30B
--
-6.77
--
3.17
--
0.14%
--
Low
--

XBI Benchmark Comparison Market Cap Size


XBI
Segment Benchmark
13.81%
--
23.10%
--
46.06%
--
17.03%
--